AL-BASSAM SADIK enters NERIUM BIOTECHNOLOGY INC with 3.06M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/30/2020ACC: 0001019056-20-000597
3.06M
Baseline shares
100% direct
3.06M
Direct ownership
1 position
2.25M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3.06M
Total
3.06M direct3.06M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.06M | Direct |
| Total | 3.06M | 3.06M direct |
Derivative Holdings2
Subordinated Debenture
DirectUnderlying security
Common Stock
Underlying shares
250K
Shares owned
N/A
Exercise price
0.50
Expiration
—
Exercise window
—
Subordinated Debenture
DirectUnderlying security
Common Stock
Underlying shares
2M
Shares owned
N/A
Exercise price
0.50
Expiration
—
Exercise window
—
Total
Underlying
2.25M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Subordinated Debenture Direct | Common Stock | 0.50 | — | — | 250K | N/A |
| Subordinated Debenture Direct | Common Stock | 0.50 | — | — | 2M | N/A |
| Total | 2.25M | 0.00 | ||||